Cargando…
Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experience
BACKGROUND: There is much interest in confirming whether the efficacy of abiraterone acetate (AA) demonstrated within the trial setting is reproducible in routine clinical practice. We report the clinical outcome of metastatic castration-resistant prostate cancer (mCRPC) patients treated with AA in...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802641/ https://www.ncbi.nlm.nih.gov/pubmed/27001043 http://dx.doi.org/10.1186/s12894-016-0132-z |